
A collaborative research and development program between Microbia, Inc. and DuPont Central Research & Development seeks to develop an economically viable process for a chemical currently manufactured from petrochemicalbased raw material.
From its perspective, DuPont feels that Microbia has the capability to accelerate the rate of process development for the project. John Pierce, director of DuPont's Biochemical Science & Engineering Section of Central Research & Development notes, "We believe Microbia's association analysis technologies will more rapidly identify those genetic elements essential for solving a complex biological challenge, and, when combined with our metabolic engineering capabilities, will accelerate our commercialization timeline."
Richard Bailey, Ph.D., vice president and general manager of Microbia's Precision Engineering business, says, "Not only does this collaboration provide further validation of our technology but it also aligns Microbia with a worldwide leader in the increasingly important area of green chemistry."

Explore the April May 2006 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Pioneering battery-free cardiac implants
- KBC Tools & Machinery marks its 60th anniversary, Founder’s Day
- Address the challenges of machining high-temperature aerospace components
- Elevate your manufacturing operations with April’s Manufacturing Lunch + Learn
- AdvaMed statement on tariff announcement
- Collets – Not all are created equal
- ENGEL expands production capacities in the Americas; new plant opened in Mexico
- MFI brings fast, high-polishing additive parts finishing to Rapid + TCT 2025